For the Inventor, By the Inventor

Enter inventor name

Scarsdale, NY, United States of America

Paul J Maddon

USPTO Granted Patents = 48 (Patent Applications = 13)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.0

ph-index = 14

Forward Citations = 480(Granted Patents)

Location History:

New York, NY (US) (1992 - 2008)
Elmsford, NY (US) (2000 - 2011)
Scarsdale, NY (US) (2004 - 2019)

Company Filing History:

Progenics Pharmaceuticals, Inc.

Columbia University

Psma Development Company, LLC

Amgen Fremont Inc.

Aaron Diamond Aids Research Centre (Adarc)

Facet Biotech Corporation

7. 2 out of 207

Smithkline Beckman Corporation

Pdl Biopharma, Inc.

Arogenics Pharmaceuticals, Inc.

11. 1 out of 832,966

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2019

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

HIV-1 Infection

PSMA Antibodies

CCR5 Chemokine Receptor

Viral Load Reduction

Envelope Glycoprotein Fusion

Chimeric Antibodies

Hepatitis C Virus Inhibition

Immunoconjugates

T Cell Surface Proteins

Fluorescence Resonance Energy Transfer

Therapeutic Antibody Compositions

Synergistic Antiviral Compositions

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10500274 - Methods for reducing viral load in HIV-1 infected patients (2019-12-10),

2. 9695248 - PSMA antibodies and uses thereof (2017-07-04),

3. 8821877 - Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist (2014-09-02),

4. 8470330 - PSMA antibodies and uses thereof (2013-06-25),

5. 8114965 - Compositions of PSMA antibodies (2012-02-14),

6. 7935797 - CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion (2011-05-03),

7. 7901685 - Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion (2011-03-08),

8. 7862994 - Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion (2011-01-04),

9. 7858298 - Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists (2010-12-28),

10. 7851600 - Anti-CCR5 antibody (2010-12-14),

11. 7850971 - PSMA antibodies and protein multimers (2010-12-14),

12. 7736649 - Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors (2010-06-15),

13. 7666419 - Anti-CCR5 antibody (2010-02-23),

14. 7592014 - Stabilized viral envelope proteins and uses thereof (2009-09-22),

15. 7479553 - Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins (2009-01-20),

Title: The Inventor Paul J Maddon: Pioneering Innovations in Scarsdale, NY

Introduction: Paul J Maddon is a distinguished inventor based in Scarsdale, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Paul J Maddon holds several patents in the areas of technology and healthcare, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Paul J Maddon has been at the forefront of developing cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Paul J Maddon has collaborated with leading experts, researchers, and institutions to further advance his inventions and bring them to market successfully.

Conclusion: Paul J Maddon's relentless pursuit of innovation and collaboration has solidified his position as a visionary inventor making significant strides in the world of technology and healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…